Most Frequent Side Effects of Trulicity
Trulicity (dulaglutide), a GLP-1 receptor agonist for type 2 diabetes, most commonly causes gastrointestinal issues. Patients report nausea in up to 20% of cases, vomiting in 5-10%, diarrhea in 12%, and abdominal pain in 7-13%. These effects often start within the first few weeks and decrease over time.[1][2]
Why Do These Side Effects Happen?
Trulicity slows gastric emptying and affects gut motility, leading to these digestive reactions. Starting at a low dose (0.75 mg weekly) and titrating up reduces severity for many users.[1]
Serious but Less Common Risks
Thyroid C-cell tumors occurred in rodent studies, prompting a boxed warning; human risk is unclear. Pancreatitis affects about 0.1-0.2% of users—seek immediate care for severe abdominal pain. Hypoglycemia risk rises when combined with insulin or sulfonylureas. Other rare issues include allergic reactions, kidney problems, or vision changes from diabetic retinopathy.[1][2]
What Patients Ask About Managing Side Effects
Nausea and diarrhea improve for 70-80% of patients after 4 weeks. Tips include eating smaller meals, avoiding fatty foods, and staying hydrated. About 4-7% discontinue due to intolerance. Consult a doctor before stopping.[1][3]
How Trulicity Side Effects Compare to Other GLP-1 Drugs
Trulicity has similar GI profile to Ozempic or Victoza but potentially milder nausea than higher-dose semaglutide. Mounjaro (tirzepatide) reports higher diarrhea rates in trials.[2][4]
Sources
[1]: Trulicity Prescribing Information (Eli Lilly)
[2]: FDA Label for Dulaglutide
[3]: Drugs.com Trulicity Side Effects
[4]: Clinical Trial Data Comparison (NEJM)